T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Trastuzumab-Deruxtecan (T-DXd)
Sponsor: MedSIR
Collaborators: Daiichi Sankyo